Global Empagliflozin API Market Research Report 2024

Report ID: 949294 | Published Date: Jan 2025 | No. of Page: 127 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Empagliflozin API Market Overview
    1.1 Product Overview and Scope of Empagliflozin API
    1.2 Empagliflozin API Segment by Type
        1.2.1 Global Empagliflozin API Market Size Growth Rate Analysis by Type 2021 VS 2027
        1.2.2 Purity≥98%
        1.2.3 Purity<98%
    1.3 Empagliflozin API Segment by Application
        1.3.1 Global Empagliflozin API Consumption Comparison by Application: 2016 VS 2021 VS 2027
        1.3.2 Empagliflozin Tablets
        1.3.3 Others
    1.4 Global Market Growth Prospects
        1.4.1 Global Empagliflozin API Revenue Estimates and Forecasts (2016-2027)
        1.4.2 Global Empagliflozin API Production Capacity Estimates and Forecasts (2016-2027)
        1.4.3 Global Empagliflozin API Production Estimates and Forecasts (2016-2027)
    1.5 Global Market Size by Region
        1.5.1 Global Empagliflozin API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
        1.5.2 India Empagliflozin API Estimates and Forecasts (2016-2027)
        1.5.3 China Empagliflozin API Estimates and Forecasts (2016-2027)
        1.5.4 South Korea Empagliflozin API Estimates and Forecasts (2016-2027)
        1.5.5 Israel Empagliflozin API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers
    2.1 Global Empagliflozin API Production Capacity Market Share by Manufacturers (2016-2021)
    2.2 Global Empagliflozin API Revenue Market Share by Manufacturers (2016-2021)
    2.3 Empagliflozin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.4 Global Empagliflozin API Average Price by Manufacturers (2016-2021)
    2.5 Manufacturers Empagliflozin API Production Sites, Area Served, Product Types
    2.6 Empagliflozin API Market Competitive Situation and Trends
        2.6.1 Empagliflozin API Market Concentration Rate
        2.6.2 Global 5 and 10 Largest Empagliflozin API Players Market Share by Revenue
        2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region
    3.1 Global Production Capacity of Empagliflozin API Market Share by Region (2016-2021)
    3.2 Global Empagliflozin API Revenue Market Share by Region (2016-2021)
    3.3 Global Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    3.4 India Empagliflozin API Production
        3.4.1 India Empagliflozin API Production Growth Rate (2016-2021)
        3.4.2 India Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    3.5 China Empagliflozin API Production
        3.5.1 China Empagliflozin API Production Growth Rate (2016-2021)
        3.5.2 China Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    3.6 South Korea Empagliflozin API Production
        3.6.1 South Korea Empagliflozin API Production Growth Rate (2016-2021)
        3.6.2 South Korea Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    3.7 Israel Empagliflozin API Production
        3.7.1 Israel Empagliflozin API Production Growth Rate (2016-2021)
        3.7.2 Israel Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Empagliflozin API Consumption by Region
    4.1 Global Empagliflozin API Consumption by Region
        4.1.1 Global Empagliflozin API Consumption by Region
        4.1.2 Global Empagliflozin API Consumption Market Share by Region
    4.2 North America
        4.2.1 North America Empagliflozin API Consumption by Country
        4.2.2 United States
        4.2.3 Canada
    4.3 Europe
        4.3.1 Europe Empagliflozin API Consumption by Country
        4.3.2 Germany
        4.3.3 France
        4.3.4 U.K.
        4.3.5 Italy
        4.3.6 Russia
    4.4 Asia Pacific
        4.4.1 Asia Pacific Empagliflozin API Consumption by Region
        4.4.2 China
        4.4.3 Japan
        4.4.4 South Korea
        4.4.5 Taiwan
        4.4.6 Southeast Asia
        4.4.7 India
        4.4.8 Australia
    4.5 Latin America
        4.5.1 Latin America Empagliflozin API Consumption by Country
        4.5.2 Mexico
        4.5.3 Brazil

5 Production, Revenue, Price Trend by Type
    5.1 Global Empagliflozin API Production Market Share by Type (2016-2021)
    5.2 Global Empagliflozin API Revenue Market Share by Type (2016-2021)
    5.3 Global Empagliflozin API Price by Type (2016-2021)

6 Consumption Analysis by Application
    6.1 Global Empagliflozin API Consumption Market Share by Application (2016-2021)
    6.2 Global Empagliflozin API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled
    7.1 Piramal Enterprises Limited
        7.1.1 Piramal Enterprises Limited Empagliflozin API Corporation Information
        7.1.2 Piramal Enterprises Limited Empagliflozin API Product Portfolio
        7.1.3 Piramal Enterprises Limited Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.1.4 Piramal Enterprises Limited Main Business and Markets Served
        7.1.5 Piramal Enterprises Limited Recent Developments/Updates
    7.2 Metrochem API Private Limited
        7.2.1 Metrochem API Private Limited Empagliflozin API Corporation Information
        7.2.2 Metrochem API Private Limited Empagliflozin API Product Portfolio
        7.2.3 Metrochem API Private Limited Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.2.4 Metrochem API Private Limited Main Business and Markets Served
        7.2.5 Metrochem API Private Limited Recent Developments/Updates
    7.3 ZCL Chemicals Limited
        7.3.1 ZCL Chemicals Limited Empagliflozin API Corporation Information
        7.3.2 ZCL Chemicals Limited Empagliflozin API Product Portfolio
        7.3.3 ZCL Chemicals Limited Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.3.4 ZCL Chemicals Limited Main Business and Markets Served
        7.3.5 ZCL Chemicals Limited Recent Developments/Updates
    7.4 Dr. Reddy's Laboratories
        7.4.1 Dr. Reddy's Laboratories Empagliflozin API Corporation Information
        7.4.2 Dr. Reddy's Laboratories Empagliflozin API Product Portfolio
        7.4.3 Dr. Reddy's Laboratories Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.4.4 Dr. Reddy's Laboratories Main Business and Markets Served
        7.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
    7.5 Teva Pharmaceutical Industries Ltd.
        7.5.1 Teva Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
        7.5.2 Teva Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
        7.5.3 Teva Pharmaceutical Industries Ltd. Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.5.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
        7.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    7.6 Sun Pharmaceutical Industries Ltd.
        7.6.1 Sun Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
        7.6.2 Sun Pharmaceutical Industries Ltd. Empagliflozin API Product Portfolio
        7.6.3 Sun Pharmaceutical Industries Ltd. Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
        7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    7.7 Hikal
        7.7.1 Hikal Empagliflozin API Corporation Information
        7.7.2 Hikal Empagliflozin API Product Portfolio
        7.7.3 Hikal Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.7.4 Hikal Main Business and Markets Served
        7.7.5 Hikal Recent Developments/Updates
    7.8 Morepen Laboratories
        7.8.1 Morepen Laboratories Empagliflozin API Corporation Information
        7.8.2 Morepen Laboratories Empagliflozin API Product Portfolio
        7.8.3 Morepen Laboratories Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.8.4 Morepen Laboratories Main Business and Markets Served
        7.7.5 Morepen Laboratories Recent Developments/Updates
    7.9 Zhejiang Huahai Pharmaceutial. Co., Ltd.
        7.9.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Corporation Information
        7.9.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Product Portfolio
        7.9.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.9.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
        7.9.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
    7.10 Lupin Ltd
        7.10.1 Lupin Ltd Empagliflozin API Corporation Information
        7.10.2 Lupin Ltd Empagliflozin API Product Portfolio
        7.10.3 Lupin Ltd Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.10.4 Lupin Ltd Main Business and Markets Served
        7.10.5 Lupin Ltd Recent Developments/Updates
    7.11 Biocon Limited
        7.11.1 Biocon Limited Empagliflozin API Corporation Information
        7.11.2 Biocon Limited Empagliflozin API Product Portfolio
        7.11.3 Biocon Limited Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.11.4 Biocon Limited Main Business and Markets Served
        7.11.5 Biocon Limited Recent Developments/Updates
    7.12 Mehta API Pvt. Ltd
        7.12.1 Mehta API Pvt. Ltd Empagliflozin API Corporation Information
        7.12.2 Mehta API Pvt. Ltd Empagliflozin API Product Portfolio
        7.12.3 Mehta API Pvt. Ltd Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.12.4 Mehta API Pvt. Ltd Main Business and Markets Served
        7.12.5 Mehta API Pvt. Ltd Recent Developments/Updates
    7.13 Danesh Kimia Pharmed
        7.13.1 Danesh Kimia Pharmed Empagliflozin API Corporation Information
        7.13.2 Danesh Kimia Pharmed Empagliflozin API Product Portfolio
        7.13.3 Danesh Kimia Pharmed Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.13.4 Danesh Kimia Pharmed Main Business and Markets Served
        7.13.5 Danesh Kimia Pharmed Recent Developments/Updates
    7.14 Shandong Haohong Biotechnology Co., Ltd.
        7.14.1 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
        7.14.2 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Product Portfolio
        7.14.3 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.14.4 Shandong Haohong Biotechnology Co., Ltd. Main Business and Markets Served
        7.14.5 Shandong Haohong Biotechnology Co., Ltd. Recent Developments/Updates
    7.15 Boryung Pharmaceutical Co., Ltd
        7.15.1 Boryung Pharmaceutical Co., Ltd Empagliflozin API Corporation Information
        7.15.2 Boryung Pharmaceutical Co., Ltd Empagliflozin API Product Portfolio
        7.15.3 Boryung Pharmaceutical Co., Ltd Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.15.4 Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
        7.15.5 Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
    7.16 Ami Lifesciences
        7.16.1 Ami Lifesciences Empagliflozin API Corporation Information
        7.16.2 Ami Lifesciences Empagliflozin API Product Portfolio
        7.16.3 Ami Lifesciences Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.16.4 Ami Lifesciences Main Business and Markets Served
        7.16.5 Ami Lifesciences Recent Developments/Updates
    7.17 Jiangsu Yutian Pharmaceutical Co., Ltd.
        7.17.1 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Corporation Information
        7.17.2 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Product Portfolio
        7.17.3 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.17.4 Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business and Markets Served
        7.17.5 Jiangsu Yutian Pharmaceutical Co., Ltd. Recent Developments/Updates
    7.18 SGMR Pharmaceuticals
        7.18.1 SGMR Pharmaceuticals Empagliflozin API Corporation Information
        7.18.2 SGMR Pharmaceuticals Empagliflozin API Product Portfolio
        7.18.3 SGMR Pharmaceuticals Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.18.4 SGMR Pharmaceuticals Main Business and Markets Served
        7.18.5 SGMR Pharmaceuticals Recent Developments/Updates
    7.19 Kopran Limited
        7.19.1 Kopran Limited Empagliflozin API Corporation Information
        7.19.2 Kopran Limited Empagliflozin API Product Portfolio
        7.19.3 Kopran Limited Empagliflozin API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
        7.19.4 Kopran Limited Main Business and Markets Served
        7.19.5 Kopran Limited Recent Developments/Updates

8 Empagliflozin API Manufacturing Cost Analysis
    8.1 Empagliflozin API Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Raw Materials Price Trend
        8.1.3 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Empagliflozin API
    8.4 Empagliflozin API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Empagliflozin API Distributors List
    9.3 Empagliflozin API Customers

10 Market Dynamics
    10.1 Empagliflozin API Industry Trends
    10.2 Empagliflozin API Growth Drivers
    10.3 Empagliflozin API Market Challenges
    10.4 Empagliflozin API Market Restraints

11 Production and Supply Forecast
    11.1 Global Forecasted Production of Empagliflozin API by Region (2022-2027)
    11.2 India Empagliflozin API Production, Revenue Forecast (2022-2027)
    11.3 China Empagliflozin API Production, Revenue Forecast (2022-2027)
    11.4 South Korea Empagliflozin API Production, Revenue Forecast (2022-2027)
    11.5 Israel Empagliflozin API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast
    12.1 Global Forecasted Demand Analysis of Empagliflozin API
    12.2 North America Forecasted Consumption of Empagliflozin API by Country
    12.3 Europe Market Forecasted Consumption of Empagliflozin API by Country
    12.4 Asia Pacific Market Forecasted Consumption of Empagliflozin API by Region
    12.5 Latin America Forecasted Consumption of Empagliflozin API by Country

13 Forecast by Type and by Application (2022-2027)
    13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
        13.1.1 Global Forecasted Production of Empagliflozin API by Type (2022-2027)
        13.1.2 Global Forecasted Revenue of Empagliflozin API by Type (2022-2027)
        13.1.3 Global Forecasted Price of Empagliflozin API by Type (2022-2027)
    13.2 Global Forecasted Consumption of Empagliflozin API by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source
    15.1 Methodology/Research Approach
        15.1.1 Research Programs/Design
        15.1.2 Market Size Estimation
        15.1.3 Market Breakdown and Data Triangulation
    15.2 Data Source
        15.2.1 Secondary Sources
        15.2.2 Primary Sources
    15.3 Author List
    15.4 Disclaimer
List of Tables
    Table 1. Global Empagliflozin API Market Size by Type (Ton) & (US$ Million) (2021 VS 2027)
    Table 2. Global Empagliflozin API Consumption (Ton) Comparison by Application: 2016 VS 2021 VS 2027
    Table 3. Empagliflozin API Market Size Comparison by Region: 2016 VS 2021 VS 2027
    Table 4. Global Empagliflozin API Production Capacity (Ton) by Manufacturers
    Table 5. Global Empagliflozin API Production (Ton) by Manufacturers (2016-2021)
    Table 6. Global Empagliflozin API Production Market Share by Manufacturers (2016-2021)
    Table 7. Global Empagliflozin API Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Empagliflozin API Revenue Share by Manufacturers (2016-2021)
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Empagliflozin API as of 2020)
    Table 10. Global Market Empagliflozin API Average Price (US$/Ton) of Key Manufacturers (2016-2021)
    Table 11. Manufacturers Empagliflozin API Production Sites and Area Served
    Table 12. Manufacturers Empagliflozin API Product Types
    Table 13. Mergers & Acquisitions, Expansion
    Table 14. Global Empagliflozin API Production Capacity (Ton) by Region (2016-2021)
    Table 15. Global Empagliflozin API Production (Ton) by Region (2016-2021)
    Table 16. Global Empagliflozin API Revenue (US$ Million) by Region (2016-2021)
    Table 17. Global Empagliflozin API Revenue Market Share by Region (2016-2021)
    Table 18. Global Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 19. India Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 20. China Empagliflozin API Production (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 21. South Korea Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 22. Israel Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 23. Global Empagliflozin API Consumption Market by Region (2016-2021) & (Ton)
    Table 24. Global Empagliflozin API Consumption Market Share by Region (2016-2021)
    Table 25. North America Empagliflozin API Consumption by Country (2016-2021) & (Ton)
    Table 26. Europe Empagliflozin API Consumption by Country (2016-2021) & (Ton)
    Table 27. Asia Pacific Empagliflozin API Consumption by Region (2016-2021) & (Ton)
    Table 28. Latin America Empagliflozin API Consumption by Countries (2016-2021) & (Ton)
    Table 29. Global Empagliflozin API Production (Ton) by Type (2016-2021)
    Table 30. Global Empagliflozin API Production Market Share by Type (2016-2021)
    Table 31. Global Empagliflozin API Revenue (US$ Million) by Type (2016-2021)
    Table 32. Global Empagliflozin API Revenue Share by Type (2016-2021)
    Table 33. Global Empagliflozin API Price (US$/Ton) by Type (2016-2021)
    Table 34. Global Empagliflozin API Consumption by Application (2016-2021) & (Ton)
    Table 35. Global Empagliflozin API Consumption Market Share by Application (2016-2021)
    Table 36. Global Empagliflozin API Consumption Growth Rate by Application (2016-2021)
    Table 37. Piramal Enterprises Limited Empagliflozin API Corporation Information
    Table 38. Piramal Enterprises Limited Specification and Application
    Table 39. Piramal Enterprises Limited Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 40. Piramal Enterprises Limited Main Business and Markets Served
    Table 41. Piramal Enterprises Limited Recent Developments/Updates
    Table 42. Metrochem API Private Limited Empagliflozin API Corporation Information
    Table 43. Metrochem API Private Limited Specification and Application
    Table 44. Metrochem API Private Limited Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 45. Metrochem API Private Limited Main Business and Markets Served
    Table 46. Metrochem API Private Limited Recent Developments/Updates
    Table 47. ZCL Chemicals Limited Empagliflozin API Corporation Information
    Table 48. ZCL Chemicals Limited Specification and Application
    Table 49. ZCL Chemicals Limited Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 50. ZCL Chemicals Limited Main Business and Markets Served
    Table 51. ZCL Chemicals Limited Recent Developments/Updates
    Table 52. Dr. Reddy's Laboratories Empagliflozin API Corporation Information
    Table 53. Dr. Reddy's Laboratories Specification and Application
    Table 54. Dr. Reddy's Laboratories Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 55. Dr. Reddy's Laboratories Main Business and Markets Served
    Table 56. Dr. Reddy's Laboratories Recent Developments/Updates
    Table 57. Teva Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
    Table 58. Teva Pharmaceutical Industries Ltd. Specification and Application
    Table 59. Teva Pharmaceutical Industries Ltd. Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 60. Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
    Table 61. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 62. Sun Pharmaceutical Industries Ltd. Empagliflozin API Corporation Information
    Table 63. Sun Pharmaceutical Industries Ltd. Specification and Application
    Table 64. Sun Pharmaceutical Industries Ltd. Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 65. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
    Table 66. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 67. Hikal Empagliflozin API Corporation Information
    Table 68. Hikal Specification and Application
    Table 69. Hikal Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 70. Hikal Main Business and Markets Served
    Table 71. Hikal Recent Developments/Updates
    Table 72. Morepen Laboratories Empagliflozin API Corporation Information
    Table 73. Morepen Laboratories Specification and Application
    Table 74. Morepen Laboratories Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 75. Morepen Laboratories Main Business and Markets Served
    Table 76. Morepen Laboratories Recent Developments/Updates
    Table 77. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Corporation Information
    Table 78. Zhejiang Huahai Pharmaceutial. Co., Ltd. Specification and Application
    Table 79. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 80. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
    Table 81. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
    Table 82. Lupin Ltd Empagliflozin API Corporation Information
    Table 83. Lupin Ltd Specification and Application
    Table 84. Lupin Ltd Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 85. Lupin Ltd Main Business and Markets Served
    Table 86. Lupin Ltd Recent Developments/Updates
    Table 87. Biocon Limited Empagliflozin API Corporation Information
    Table 88. Biocon Limited Specification and Application
    Table 89. Biocon Limited Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 90. Biocon Limited Main Business and Markets Served
    Table 91. Biocon Limited Recent Developments/Updates
    Table 92. Mehta API Pvt. Ltd Empagliflozin API Corporation Information
    Table 93. Mehta API Pvt. Ltd Specification and Application
    Table 94. Mehta API Pvt. Ltd Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 95. Mehta API Pvt. Ltd Main Business and Markets Served
    Table 96. Mehta API Pvt. Ltd Recent Developments/Updates
    Table 97. Danesh Kimia Pharmed Empagliflozin API Corporation Information
    Table 98. Danesh Kimia Pharmed Specification and Application
    Table 99. Danesh Kimia Pharmed Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 100. Danesh Kimia Pharmed Main Business and Markets Served
    Table 101. Danesh Kimia Pharmed Recent Developments/Updates
    Table 102. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
    Table 103. Shandong Haohong Biotechnology Co., Ltd. Specification and Application
    Table 104. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 105. Shandong Haohong Biotechnology Co., Ltd. Main Business and Markets Served
    Table 106. Lupin Ltd Recent Developments/Updates
    Table 107. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Corporation Information
    Table 108. Boryung Pharmaceutical Co., Ltd Specification and Application
    Table 109. Boryung Pharmaceutical Co., Ltd Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 110. Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
    Table 111. Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
    Table 112. Ami Lifesciences Empagliflozin API Corporation Information
    Table 113. Ami Lifesciences Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 114. Ami Lifesciences Main Business and Markets Served
    Table 115. Ami Lifesciences Recent Developments/Updates
    Table 116. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Corporation Information
    Table 117. Jiangsu Yutian Pharmaceutical Co., Ltd. Specification and Application
    Table 118. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 119. Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business and Markets Served
    Table 120. Jiangsu Yutian Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 121. SGMR Pharmaceuticals Empagliflozin API Corporation Information
    Table 122. SGMR Pharmaceuticals Specification and Application
    Table 123. SGMR Pharmaceuticals Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 124. SGMR Pharmaceuticals Main Business and Markets Served
    Table 125. SGMR Pharmaceuticals Recent Developments/Updates
    Table 126. Kopran Limited Empagliflozin API Corporation Information
    Table 127. Kopran Limited Specification and Application
    Table 128. Kopran Limited Empagliflozin API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 129. Kopran Limited Main Business and Markets Served
    Table 130. Kopran Limited Recent Developments/Updates
    Table 131. Production Base and Market Concentration Rate of Raw Material
    Table 132. Key Suppliers of Raw Materials
    Table 133. Empagliflozin API Distributors List
    Table 134. Empagliflozin API Customers List
    Table 135. Empagliflozin API Market Trends
    Table 136. Empagliflozin API Growth Drivers
    Table 137. Empagliflozin API Market Challenges
    Table 138. Empagliflozin API Market Restraints
    Table 139. Global Empagliflozin API Production (Ton) Forecast by Region (2022-2027)
    Table 140. North America Empagliflozin API Consumption Forecast by Country (2022-2027) & (Ton)
    Table 141. Europe Empagliflozin API Consumption Forecast by Country (2022-2027) & (Ton)
    Table 142. Asia Pacific Empagliflozin API Consumption Forecast by Region (2022-2027) & (Ton)
    Table 143. Latin America Empagliflozin API Consumption Forecast by Country (2022-2027) & (Ton)
    Table 144. Global Empagliflozin API Production Forecast by Type (2022-2027) & (Ton)
    Table 145. Global Empagliflozin API Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 146. Global Empagliflozin API Price Forecast by Type (2022-2027) & (US$/Ton)
    Table 147. Global Empagliflozin API Consumption (Ton) Forecast by Application (2022-2027)
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Empagliflozin API
    Figure 2. Global Empagliflozin API Market Share by Type: 2020 VS 2027
    Figure 3. Purity≥98% Product Picture
    Figure 4. Purity<98% Product Picture
    Figure 5. Global Empagliflozin API Market Share by Application: 2020 VS 2027
    Figure 6. Empagliflozin Tablets
    Figure 7. Others
    Figure 8. Global Empagliflozin API Revenue (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Empagliflozin API Revenue (US$ Million) (2016-2027)
    Figure 10. Global Empagliflozin API Production Capacity (Ton) & (2016-2027)
    Figure 11. Global Empagliflozin API Production (Ton) & (2016-2027)
    Figure 12. India Empagliflozin API Revenue (US$ Million) and Growth Rate (2016-2027)
    Figure 13. China Empagliflozin API Revenue (US$ Million) and Growth Rate (2016-2027)
    Figure 14. South Korea Empagliflozin API Revenue (US$ Million) and Growth Rate (2016-2027)
    Figure 15. Israel Empagliflozin API Revenue (US$ Million) and Growth Rate (2016-2027)
    Figure 16. Empagliflozin API Production Share by Manufacturers in 2020
    Figure 17. Global Empagliflozin API Revenue Share by Manufacturers in 2020
    Figure 18. Empagliflozin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 19. Global Market Empagliflozin API Average Price (US$/Ton) of Key Manufacturers in 2020
    Figure 20. The Global 5 and 10 Largest Players: Market Share by Empagliflozin API Revenue in 2020
    Figure 21. Global Empagliflozin API Production Market Share by Region (2016-2021)
    Figure 22. India Empagliflozin API Production (Ton) Growth Rate (2016-2021)
    Figure 23. China Empagliflozin API Production (Ton) Growth Rate (2016-2021)
    Figure 24. South Korea Empagliflozin API Production (Ton) Growth Rate (2016-2021)
    Figure 25. Israel Empagliflozin API Production (Ton) Growth Rate (2016-2021)
    Figure 26. Global Empagliflozin API Consumption Market Share by Region (2016-2021)
    Figure 27. Global Empagliflozin API Consumption Market Share by Region in 2020
    Figure 28. North America Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 29. North America Empagliflozin API Consumption Market Share by Country in 2020
    Figure 30. Canada Empagliflozin API Consumption Growth Rate (2016-2021) & (Ton)
    Figure 31. U.S. Empagliflozin API Consumption Growth Rate (2016-2021) & (Ton)
    Figure 32. Europe Empagliflozin API Consumption Growth Rate (2016-2021) & (Ton)
    Figure 33. Europe Empagliflozin API Consumption Market Share by Country in 2020
    Figure 34. Germany America Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 35. France Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 36. U.K. Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 37. Italy Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 38. Russia Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 39. Asia Pacific Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 40. Asia Pacific Empagliflozin API Consumption Market Share by Regions in 2020
    Figure 41. China Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 42. Japan Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 43. South Korea Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 44. Taiwan Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 45. Southeast Asia Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 46. India Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 47. Australia Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 48. Latin America Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 49. Latin America Empagliflozin API Consumption Market Share by Country in 2020
    Figure 50. Mexico Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 51. Brazil Empagliflozin API Consumption and Growth Rate (2016-2021) & (Ton)
    Figure 52. Production Market Share of Empagliflozin API by Type (2016-2021)
    Figure 53. Production Market Share of Empagliflozin API by Type in 2020
    Figure 54. Revenue Share of Empagliflozin API by Type (2016-2021)
    Figure 55. Revenue Market Share of Empagliflozin API by Type in 2020
    Figure 56. Global Empagliflozin API Consumption Market Share by Application (2016-2021)
    Figure 57. Global Empagliflozin API Consumption Market Share by Application in 2020
    Figure 58. Global Empagliflozin API Consumption Growth Rate by Application (2016-2021)
    Figure 59. Key Raw Materials Price Trend
    Figure 60. Manufacturing Cost Structure of Empagliflozin API
    Figure 61. Manufacturing Process Analysis of Empagliflozin API
    Figure 62. Empagliflozin API Industrial Chain Analysis
    Figure 63. Channels of Distribution
    Figure 64. Distributors Profiles
    Figure 65. Global Empagliflozin API Production Market Share Forecast by Region (2022-2027)
    Figure 66. India Empagliflozin API Production (Ton) Growth Rate Forecast (2022-2027)
    Figure 67. China Empagliflozin API Production (Ton) Growth Rate Forecast (2022-2027)
    Figure 68. South Korea Empagliflozin API Production (Ton) Growth Rate Forecast (2022-2027)
    Figure 69. Israel Empagliflozin API Production (Ton) Growth Rate Forecast (2022-2027)
    Figure 70. Global Forecasted Demand Analysis of Empagliflozin API (2015-2027) & (Ton)
    Figure 71. Global Empagliflozin API Production Market Share Forecast by Type (2022-2027)
    Figure 72. Global Empagliflozin API Revenue Market Share Forecast by Type (2022-2027)
    Figure 73. Global Empagliflozin API Consumption Forecast by Application (2022-2027)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Piramal Enterprises Limited
Metrochem API Private Limited
ZCL Chemicals Limited
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikal
Morepen Laboratories
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Lupin Ltd
Biocon Limited
Mehta API Pvt. Ltd
Danesh Kimia Pharmed
Shandong Haohong Biotechnology Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Ami Lifesciences
Jiangsu Yutian Pharmaceutical Co., Ltd.
SGMR Pharmaceuticals
Kopran Limited
Frequently Asked Questions
Empagliflozin API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Empagliflozin API report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Empagliflozin API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Varenicline Tartrate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Baclofen API

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More